Hydrogen‐Bonded Organic Framework Nanoscintillators for X‐Ray‐Induced Photodynamic Therapy in Hepatocellular Carcinoma
Lihui Gu,
No information about this author
Han Wu,
No information about this author
Xu Li
No information about this author
et al.
Advanced Materials,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 10, 2025
Abstract
X‐ray
induced
photodynamic
therapy
(X‐PDT)
leverages
penetrating
to
generate
singlet
oxygen
(
1
O
2
)
for
treating
deep‐seated
tumors.
However,
conventional
X‐PDT
typically
relies
on
heavy
metal
inorganic
scintillators
and
organic
photosensitizers
produce
,
which
presents
challenges
related
toxicity
energy
conversion
efficiency.
In
this
study,
highly
biocompatible
phosphorescent
nanoscintillators
based
hydrogen‐bonded
frameworks
(HOF)
are
designed
engineered,
termed
BPT‐HOF@PEG,
enhance
in
hepatocellular
carcinoma
(HCC)
treatment.
BPT‐HOF@PEG
functions
simultaneously
as
both
scintillator
photosensitizer,
effectively
absorbing
transferring
abundant
.
Both
vitro
vivo
investigations
demonstrate
that
internalized
efficiently
produces
significant
quantities
of
upon
irradiation.
Additionally,
exposure
directly
inflicts
DNA
damage,
the
synergistic
effects
these
mechanisms
result
pronounced
cell
death
substantial
tumor
growth
inhibition,
with
a
inhibition
rate
up
90.4%
assessments.
RNA
sequencing
analyses
reveal
induces
apoptosis
Hepa1‐6
cells
while
inhibiting
proliferation,
culminating
death.
Therefore,
work
highlights
considerable
potential
efficient
HOF
nanoscintillators‐based
promising
therapeutic
approach
HCC,
providing
effective
alternative
negligible
patients
unresectable
Language: Английский
Dimerized Pentamethine Cyanines for Synergistically Boosting Photodynamic/Photothermal Therapy
Haiqiao Huang,
No information about this author
Qiang Liu,
No information about this author
Jinghui Zhu
No information about this author
et al.
Aggregate,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 18, 2024
ABSTRACT
Photodynamic
therapy
(PDT)
and
photothermal
(PTT)
have
emerged
promising
applications
in
both
fundamental
research
clinical
trials.
However,
it
remains
challenging
to
develop
ideal
photosensitizers
(PSs)
that
concurrently
integrate
high
photostability,
large
near‐infrared
absorptivity,
efficient
therapeutic
capabilities.
Herein,
we
reported
a
sample
engineering
strategy
afford
benzene‐fused
Cy5
dimer
(
Cy‐D‐5
)
for
synergistically
boosting
PDT/PTT
applications.
Intriguingly,
exhibits
tendency
form
J
‐aggregates
H
phosphate‐buffered
saline,
which
show
long‐wavelength
absorption
band
bathochromically
shifted
810
nm
short‐wavelength
hypsochromically
745
nm,
respectively,
when
compared
its
behavior
ethanol
(778
nm).
Density‐functional
theory
calculations
combined
with
time‐resolved
transient
optical
spectroscopy
analysis
reveal
the
fused
low
Δ
E
ST
(0.51
eV)
non‐radiative
transition
rates
(12.6
times
greater
than
of
clinically
approved
PS‐indocyanine
green
[PS‐
ICG
]).
Furthermore,
demonstrates
higher
photosensitizing
ability
produce
1
O
2
,
stronger
conversion
efficiency
η
=
64.4%),
photostability
.
These
properties
enable
achieve
complete
tumor
ablation
upon
808
laser
irradiation,
highlighting
potential
as
powerful
dual‐function
phototherapeutic
agent.
This
work
may
offer
practical
other
existing
dyes
red‐shifted
spectral
range
various
phototherapy
Language: Английский
Implantable, flexible biophotonic device for wireless photodynamic therapy of postoperative infection and tumor recurrence
Jianhong Zhang,
No information about this author
Renhao Nie,
No information about this author
Qingyan Jia
No information about this author
et al.
Device,
Journal Year:
2025,
Volume and Issue:
unknown, P. 100754 - 100754
Published: March 1, 2025
Language: Английский
Possible integration of artificial intelligence with photodynamic therapy and diagnosis: A review
Journal of Drug Delivery Science and Technology,
Journal Year:
2024,
Volume and Issue:
101, P. 106210 - 106210
Published: Sept. 16, 2024
Language: Английский
Precise HER2 Protein Degradation via Peptide‐Conjugated Photodynamic Therapy for Enhanced Breast Cancer Immunotherapy
Advanced Science,
Journal Year:
2024,
Volume and Issue:
12(2)
Published: Nov. 18, 2024
Abstract
Breast
cancer,
the
most
prevalent
malignancy
among
women,
frequently
exhibits
high
HER2
expression,
making
a
critical
therapeutic
target.
Traditional
treatments
combining
anti‐HER2
antibody
trastuzumab
with
immunotherapy
face
limitations
due
to
toxicity
and
tumor
microenvironment
immunosuppression.
This
study
introduces
an
innovative
strategy
HER2‐targeting
peptides
photosensitizer
(PSs)
pyropheophorbide‐a
(Pha)
via
gelatinase‐cleavable
linker,
forming
self‐assembling
nanoparticles.
These
nanoparticles
actively
target
breast
cancer
cells
generate
reactive
oxygen
species
(ROS)
under
near‐infrared
light,
effectively
degrading
proteins.
Upon
internalization,
linker
is
cleaved,
releasing
Pha‐PLG
enhancing
intracellular
photodynamic
therapy
(PDT).
The
molecules
self‐assemble
into
nanofibers,
prolonging
circulation,
boosting
immune
induction,
activating
CD8
+
T
cells,
thus
promoting
robust
anti‐tumor
response.
In
vivo,
studies
confirm
superior
biosafety,
targeting,
degradation,
increased
cytotoxic
cell
activity
improved
antitumor
immunity.
integrated
offers
promising
new
avenue
for
treatment.
Language: Английский